PMC:7247521 / 44652-44891
Annnotations
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T680 | 47-56 | CHEBI:36357;CHEBI:36357 | denotes | compounds |
| T681 | 168-174 | CHEBI:30563;CHEBI:30563 | denotes | silico |
| T682 | 175-179 | CHEBI:23888;CHEBI:23888 | denotes | drug |
| T683 | 211-227 | UBERON:0005409 | denotes | gastrointestinal |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T402 | 189-193 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | test |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T353 | 104-106 | Chemical | denotes | MW | http://purl.obolibrary.org/obo/CHEBI_74709 |
| T354 | 175-179 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T332 | 0-239 | Sentence | denotes | In our study, ADMETox evaluation shows that 20 compounds passed the stringent lead-like criteria (250 ≤ MW≤350 & XLOGP ≤ 3.5 & Number of rotatable bonds≤7) [40] and in silico drug-likeness test, and showed high gastrointestinal absorption. |